Viewing Study NCT02766634


Ignite Creation Date: 2025-12-25 @ 2:26 AM
Ignite Modification Date: 2026-02-26 @ 12:27 AM
Study NCT ID: NCT02766634
Status: COMPLETED
Last Update Posted: 2016-07-21
First Post: 2016-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ZIN-FIL-1501
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View